LAKISHA HIGHE: Open Payments
NPI 1275249971 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,314 in 131 payments from 25 companies in 2025. Trend: 2023 $1,006 · 2024 $2,619 · 2025 $3,314
Food & beverage: $3,314
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 24 | $535 |
| UCB, Inc. | 14 | $481 |
| ABBVIE INC. | 16 | $391 |
| AstraZeneca Pharmaceuticals LP | 8 | $379 |
| Novartis Pharmaceuticals Corporation | 15 | $294 |
| Janssen Biotech, Inc. | 14 | $218 |
| E.R. Squibb & Sons, L.L.C. | 5 | $129 |
| ANI Pharmaceuticals, Inc. | 5 | $108 |
| GlaxoSmithKline, LLC. | 3 | $86 |
| TerSera Therapeutics LLC | 3 | $86 |
Products named: Bimzelx, SAPHNELO, COSENTYX, RINVOQ, EVENITY, TREMFYA, SKYRIZI, ORENCIA.
Industry payments across NC — which companies pay providers there.
